Progress in microneedle array patch (MAP) for vaccine delivery
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nguyen, T.T. | - |
dc.contributor.author | Oh, Yujeong | - |
dc.contributor.author | Kim, Yunseo | - |
dc.contributor.author | Shin, Yura | - |
dc.contributor.author | Baek, Seung-Ki | - |
dc.contributor.author | Park, Jung-Hwan | - |
dc.date.available | 2021-02-18T00:40:18Z | - |
dc.date.created | 2020-07-27 | - |
dc.date.issued | 2021-01 | - |
dc.identifier.issn | 2164-5515 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/79985 | - |
dc.description.abstract | A microneedle array patch (MAP) has been developed as a new delivery system for vaccines. Preclinical and clinical trials with a vaccine MAP showed improved stability, safety, and immunological efficacy compared to conventional vaccine administration. Various vaccines can be delivered with a MAP. Currently, microneedle manufacturers can mass-produce pharmaceutical MAP and cosmetic MAP and this mass-production system can be adapted to produce a vaccine MAP. Clinical trials with a vaccine MAP have shown comparable efficacy with conventional administration, and discussions about regulations for a vaccine MAP are underway. However, there are concerns of reasonable cost, mass production, efficacy, and safety standards that meet FDA approval, as well as the need for feedback regarding the best method of administration. Currently, microneedles have been studied for the delivery of many kinds of vaccines, and preclinical and clinical studies of vaccine microneedles are in progress. For the foreseeable future, some vaccines will continue to be administered with syringes and needles while the use of a vaccine MAP continues to be improved because of the advantages of less pain, self-administration, improved stability, convenience, and safety. © 2020, © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | TAYLOR & FRANCIS INC | - |
dc.relation.isPartOf | HUMAN VACCINES & IMMUNOTHERAPEUTICS | - |
dc.title | Progress in microneedle array patch (MAP) for vaccine delivery | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000548995500001 | - |
dc.identifier.doi | 10.1080/21645515.2020.1767997 | - |
dc.identifier.bibliographicCitation | HUMAN VACCINES & IMMUNOTHERAPEUTICS, v.17, no.1, pp.316 - 327 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85088152722 | - |
dc.citation.endPage | 327 | - |
dc.citation.startPage | 316 | - |
dc.citation.title | HUMAN VACCINES & IMMUNOTHERAPEUTICS | - |
dc.citation.volume | 17 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Oh, Yujeong | - |
dc.contributor.affiliatedAuthor | Kim, Yunseo | - |
dc.contributor.affiliatedAuthor | Shin, Yura | - |
dc.contributor.affiliatedAuthor | Park, Jung-Hwan | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | development | - |
dc.subject.keywordAuthor | microneedles | - |
dc.subject.keywordAuthor | status | - |
dc.subject.keywordAuthor | vaccine | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.